KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Depreciation & Amortization (CF) (2016 - 2025)

Thermo Fisher Scientific's Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $292.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 3.95% year-over-year to $292.0 million, compared with a TTM value of $1.1 billion through Dec 2025, down 9.08%, and an annual FY2025 reading of $1.0 billion, down 9.17% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $292.0 million at Thermo Fisher Scientific, up from $227.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $304.0 million in Q4 2024, with the low at $198.0 million in Q2 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $254.6 million, with a median of $256.0 million recorded in 2022.
  • Year-over-year, Depreciation & Amortization (CF) surged 34.39% in 2021 and then dropped 21.99% in 2025.
  • Tracing TMO's Depreciation & Amortization (CF) over 5 years: stood at $217.0 million in 2021, then grew by 17.97% to $256.0 million in 2022, then grew by 7.81% to $276.0 million in 2023, then grew by 10.14% to $304.0 million in 2024, then fell by 3.95% to $292.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Depreciation & Amortization (CF) are $292.0 million (Q4 2025), $227.0 million (Q3 2025), and $256.0 million (Q2 2025).